Abstract: An apparatus for supporting signage at a support structure is disclosed. The apparatus has a torsion member configured to be attached to the signage, at least one base member configured to be attached to the support structure, and at least one hinge assembly that is disposed between the torsion member and the at least one base member, the at least one hinge assembly including a base hinge subassembly and a second hinge subassembly that are attached together. The base hinge subassembly is attached to the at least one base member. The second hinge subassembly is attached to the torsion member. The torsion member is rotatable in a first rotational direction about the second hinge subassembly and a second rotational direction about the base hinge subassembly, the first rotational direction being different from the second rotational direction.

Abstract: One embodiment is an aircraft including first and second fuselages; a wing assembly connecting the first and second fuselages, wherein the first and second fuselages are parallel to one another; first and second forward propulsion systems tiltably attached to forward ends of the first and second fuselages; and first and second aft propulsion systems fixedly attached proximate aft ends of the first and second fuselages.

Abstract: One embodiment is an aircraft including first and second fuselages; a wing assembly connecting the first and second fuselages, wherein the first and second fuselages are parallel to one another; first and second forward propulsion systems tiltably attached to forward ends of the first and second fuselages; and first and second aft propulsion systems fixedly attached proximate aft ends of the first and second fuselages.

Abstract: A stowable lift rotor is coupled to an airframe of a VTOL aircraft. The VTOL aircraft is convertible between a VTOL flight mode and a forward flight mode. The stowable lift rotor includes a lift arm. The proximal end of the lift arm is coupled to the airframe of the VTOL aircraft. The stowable lift rotor also includes a rotor assembly including rotor blades coupled to the distal end of the lift arm. The lift arm is movable between various positions including an extended position in the VTOL flight mode, a stowed position in the forward flight mode and intermediate positions therebetween such that the distance between the rotor assembly and the airframe is greater in the extended position than in the stowed position.

Abstract: A composition for the colorimetric quantification of corrosion inhibiting compounds in an industrial fluid, including an analytic reagent composition comprised of a non-aqueous transition metal-ligand solution mixed with a corrosion inhibitor containing fluid, where the combination produces a color change that quantifies the amount of the corrosion inhibitor in the fluid.

Abstract: A stowable lift rotor is coupled to an airframe of a VTOL aircraft. The VTOL aircraft is convertible between a VTOL flight mode and a forward flight mode. The stowable lift rotor includes a lift arm. The proximal end of the lift arm is coupled to the airframe of the VTOL aircraft. The stowable lift rotor also includes a rotor assembly including rotor blades coupled to the distal end of the lift arm. The lift arm is movable between various positions including an extended position in the VTOL flight mode, a stowed position in the forward flight mode and intermediate positions therebetween such that the distance between the rotor assembly and the airframe is greater in the extended position than in the stowed position.

Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.

Abstract: A method of design optimization includes training adversarial combined networks including a discriminator network and a generator network. The method is capable of performing multi-objective optimization and may be more efficient than existing methods for certain problems.

Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.

Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.

Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.

Abstract: The present invention provides a method for altering the pharmacokinetics of mifepristone upon oral administration. Mifepristone absorption into the blood is increased upon administration with meals. The method of the invention can benefit patients suffering from conditions including psychiatric illnesses and hormonal disorders.

Abstract: A method for forming a compound film includes the steps of preparing a source material, depositing the source material on a base and forming a preparatory film from the source material, heating the preparatory film in a suitable atmosphere to form a precursor film, and providing suitable material to said precursor film to form the compound film. The source material includes oxide-containing particles including Group IB and IIIA elements. The precursor film includes non-oxide Group IB and IIIA elements. The compound film includes a Group IB-IIIA-VIA compound. The oxides may constitute greater than about 95 molar percent of the Group IB elements and greater than about 95 molar percent of the Group IIIA elements in the source material. Similarly, non-oxides may constitute greater than about 95 molar percent of the Group IB elements and greater than about 95 molar percent of the Group IIIA elements in the precursor film.

Abstract: A method of forming a compound film includes the steps of preparing a source material, depositing the source material on a base to form a precursor film, and heating the precursor film in a suitable atmosphere to form a film. The source material includes Group IB-IIIA alloy-containing particles having at least one Group IB-IIIA alloy phase, with Group IB-IIIA alloys constituting greater than about 50 molar percent of the Group IB elements and greater than about 50 molar percent of the Group IIIA elements in the source material. The film, then, includes a Group IB-IIIA-VIA compound. The molar ratio of Group IB to Group IIIA elements in the source material may be greater than about 0.80 and less than about 1.0, or substantially greater than 1.0, in which case this ratio in the compound film may be reduced to greater than about 0.80 and less than about 1.0. The source material may be prepared as an ink from particles in powder form. The alloy phase may include a dopant.

Abstract: A new and distinct cultivar of Philodendron Red Moon named ‘Fire Moon’ particularly characterized by its distinctive leaf appearance; large plant size; mostly open and outwardly spreading fuller plant habit; vigor and slow growth rate; less-freely branching; flat leaves; and long and wide petioles with long petiole sheaths.